R. David Hoover - 13 Mar 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: Director
Signature: /s/ Catherine S. Powell, as Attorney-in-Fact for R. David Hoover
Issuer symbol: ELAN
Transactions as of: 13 Mar 2023
Net transactions value: +$95,038
Form type: 4
Filing time: 15 Mar 2023, 16:21:25 UTC
Previous filing: 07 Mar 2023
Next filing: 04 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Purchase	$47,288	+5,000	+3.2%	$9.46	160,000	13 Mar 2023	Revocable Trust	F1
transaction	ELAN	Common Stock	Purchase	$47,750	+5,000	+3.1%	$9.55	165,000	14 Mar 2023	Revocable Trust
holding	ELAN	Common Stock						57,916	13 Mar 2023	Direct
holding	ELAN	Common Stock						15,920	13 Mar 2023	Suzanne A. Hoover Revocable Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 13, 2023 with purchase prices ranging from $9.455 to $9.4578 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Content

Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 13, 2023 with purchase prices ranging from $9.455 to $9.4578 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.